Antibodies against JAM-C and soluble JAM-C both efficiently block the recruitment of leukocytes in several inflammatory models in vivo, including cutaneous inflammation, peritonitis and lung inflammation34, 35, 36. This evidence concerns the gene JAM3 and peritonitis.